Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Corren, Jonathan" or (type any "bookEditor journalEditor issueEditor" and editor="Corren,...

Add to list
- Miscellaneous
- open access
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Claus Bachert (UGent) , Jonathan Corren, Stella E. Lee, Haixin Zhang, Sivan Harel, Danen Cunoosamy, Asif H. Khan, Juby A. Jacob‐Nara, Shahid Siddiqui, Scott Nash, et al.

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY.
Add to list
Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Stella E. Lee, Monica Ligueros-Saylan, Kit Wong, Theodore A. Omachi and Claus Bachert (UGent)

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.413-414
Add to list
- Conference Paper
Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials

Claus Bachert, Jonathan Corren, Stella E Lee, Haixin Zhang, Sivan Harel, Danen Cunoosamy, Asif H. Khan (UGent) , Juby A Jacob-Nara, Shahid Siddiqui and Scott Nash

(2021) International forum of allergy & rhinology.
Add to list
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly, Jonathan Corren, Peter Creticos, Frederic De Blay, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(3). p.1020-1030.e10
Add to list
- Conference Paper
- C3
Effect of Dupilumab on patient-reported breathing and rescue medication use

Jonathan Corren, Mario Castro, Jorge F Maspero, William W Busse, Antonio Valero Santiago, Piotr Kuna, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan (UGent) , et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(supplement 64).
Add to list
- Journal Article
- A1
- open access
Efficacy and safety of omalizumab in nasal polyposis : 2 randomized phase 3 trials

Philippe Gevaert (UGent) , Theodore A. Omachi, Jonathan Corren, Joaquim Mullol, Joseph Han, Stella E. Lee, Derrick Kaufman, Monica Ligueros-Saylan, Monet Howard, Rui Zhu, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 146(3). p.595-605
Add to list
Omalizumab improves quality of life in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Jonathan Corren, Claus Bachert (UGent) , Philippe Gevaert (UGent) , Joaquim Mullol, Joseph Han, Randall Ow, Sanna Toppila-Salmi, Isam Alobid, Derrick Kaufman, Jessica Braid, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB250-AB250
Add to list
Omalizumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of asthma status

Claus Bachert (UGent) , Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Randall Ow, Sanna Toppila-Salmi, Isam Alobid, Derrick Kaufman, Bongin Yoo, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB149-AB149
Add to list
- Journal Article
- A1
- open access
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W Busse, Jorge F Maspero, Yufang Lu, Jonathan Corren, Nicola A Hanania, Bradley E Chipps, Constance H Katelaris, J Mark FitzGerald, Santiago Quirce, Linda B Ford, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 125(5). p.565-576
Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma

Jonathan Corren, Mario Castro, Thomas O’Riordan, Nicola A Hanania, Ian D Pavord, Santiago Quirce, Bradley E Chipps, Sally E Wenzel, Karthinathan Thangavelu, Megan S Rice, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 8(2). p.516-526

Academic Bibliography

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Effect of Dupilumab on patient-reported breathing and rescue medication use

Efficacy and safety of omalizumab in nasal polyposis : 2 randomized phase 3 trials

Omalizumab improves quality of life in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Omalizumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of asthma status

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma

Contents

Support

Contact